2015
DOI: 10.1007/s12264-014-1513-5
|View full text |Cite
|
Sign up to set email alerts
|

Dose-dependent regulation of oligodendrocyte specification by β-catenin signaling

Abstract: Although various components of the Wnt/β-catenin pathway have been investigated, there are conflicting reports on the roles of Wnt/β-catenin signaling in oligodendrogenesis and differentiation. For instance, the ΔExon3 mutation of β-catenin [1][2][3][4] , which stabilizes β-catenin by deletion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…This is especially important as we consider the waves of gene regulation (repression and activation) that need to occur to promote myelination. Our discovery of the BHMT-betaine methylation pathway in oligodendrocytes provides insight into how epigenetics, specifically methylation through SAM, can alter DNMT and HMT activity and specifically tailor expression of both positive and negative developmental and remyelination regulators [47][48][49].…”
Section: Plos Onementioning
confidence: 99%
“…This is especially important as we consider the waves of gene regulation (repression and activation) that need to occur to promote myelination. Our discovery of the BHMT-betaine methylation pathway in oligodendrocytes provides insight into how epigenetics, specifically methylation through SAM, can alter DNMT and HMT activity and specifically tailor expression of both positive and negative developmental and remyelination regulators [47][48][49].…”
Section: Plos Onementioning
confidence: 99%
“…It is interesting that endogenous WNT/β-catenin signaling is activated in newly generated MNs [8]. Activation of WNT/β-catenin signaling has been reported to inhibit the specification of OPCs and astrocytes from NPCs during early stages of gliogenesis [9][10][11]. However, the mechanism underlying the inhibition of OPC specification from pMN NPCs by WNT/βcatenin signaling remains to be determined.…”
mentioning
confidence: 99%